These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 22864111)

  • 21. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
    Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
    Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
    Chen G; Xu S; Renko K; Derwahl M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
    Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.
    Liao J; Qian F; Tchabo N; Mhawech-Fauceglia P; Beck A; Qian Z; Wang X; Huss WJ; Lele SB; Morrison CD; Odunsi K
    PLoS One; 2014; 9(1):e84941. PubMed ID: 24409314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
    Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Proliferation Effect of Theasaponin E₁ on the ALDH-Positive Ovarian Cancer Stem-Like Cells.
    Jia LY; Xia HL; Chen ZD; Compton C; Bucur H; Sawant DA; Rankin GO; Li B; Tu YY; Chen YC
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.
    Hellsten R; Johansson M; Dahlman A; Sterner O; Bjartell A
    PLoS One; 2011; 6(7):e22118. PubMed ID: 21779382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin inhibits the development and metastasis of ovarian cancer.
    Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
    Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
    Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
    Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.
    Puvanenthiran S; Essapen S; Seddon AM; Modjtahedi H
    Int J Oncol; 2016 Nov; 49(5):1825-1838. PubMed ID: 27599579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
    Dos Santos Guimarães I; Ladislau-Magescky T; Tessarollo NG; Dos Santos DZ; Gimba ERP; Sternberg C; Silva IV; Rangel LBA
    Pharmacol Rep; 2018 Jun; 70(3):409-417. PubMed ID: 29627688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
    Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
    Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells.
    Choi YJ; Park JH; Han JW; Kim E; Jae-Wook O; Lee SY; Kim JH; Gurunathan S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer stem cells: A target for oncological therapy.
    Markowska A; Sajdak S; Huczyński A; Rehlis S; Markowska J
    Adv Clin Exp Med; 2018 Jul; 27(7):1017-1020. PubMed ID: 29938937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells.
    Siddappa G; Kulsum S; Ravindra DR; Kumar VV; Raju N; Raghavan N; Sudheendra HV; Sharma A; Sunny SP; Jacob T; Kuruvilla BT; Benny M; Antony B; Seshadri M; Lakshminarayan P; Hicks W; Suresh A; Kuriakose MA
    Mol Carcinog; 2017 Nov; 56(11):2446-2460. PubMed ID: 28618017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
    Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
    J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.